newsfilter
← Latest News
GlobeNewswire·

Angion Provides Corporate Update and Reports Second Quarter 2022 Financial Results

UNIONDALE, N.Y. , Aug. 15, 2022 (GLOBE NEWSWIRE) -- Angion Biomedica Corp (NASDAQ:ANGN), a biopharmaceutical company that has focused on the discovery, development, and commercialization of novel small molecule therapeutics to address fibrotic diseases